These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35063467)

  • 1. Manganese-induced hyperactivity and dopaminergic dysfunction depend on age, sex and YAC128 genotype.
    Wilcox JM; Consoli DC; Paffenroth KC; Spitznagel BD; Calipari ES; Bowman AB; Harrison FE
    Pharmacol Biochem Behav; 2022 Feb; 213():173337. PubMed ID: 35063467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes.
    Wilcox JM; Pfalzer AC; Tienda AA; Debbiche IF; Cox EC; Totten MS; Erikson KM; Harrison FE; Bowman AB
    Neurotoxicology; 2021 Dec; 87():94-105. PubMed ID: 34543681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism.
    Madison JL; Wegrzynowicz M; Aschner M; Bowman AB
    PLoS One; 2012; 7(2):e31024. PubMed ID: 22363539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease genotype suppresses global manganese-responsive processes in pre-manifest and manifest YAC128 mice.
    Pfalzer AC; Wilcox JM; Codreanu SG; Totten M; Bichell TJV; Halbesma T; Umashanker P; Yang KL; Parmalee NL; Sherrod SD; Erikson KM; Harrison FE; McLean JA; Aschner M; Bowman AB
    Metallomics; 2020 Jul; 12(7):1118-1130. PubMed ID: 32421118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice.
    El Fari R; Abbaoui A; Bourziq A; Zroudi M; Draoui A; El Khiat A; Belkouch M; Elgot A; Gamrani H
    J Chem Neuroanat; 2019 Dec; 102():101686. PubMed ID: 31562917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.
    Chen S; Zhang XJ; Xie WJ; Qiu HY; Liu H; Le WD
    CNS Neurosci Ther; 2015 Aug; 21(8):662-71. PubMed ID: 26122704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal Cholesterol Precursors Are Altered with Age in Female Huntington's Disease Model Mice.
    Pfalzer AC; Wages PA; Porter NA; Bowman AB
    J Huntingtons Dis; 2019; 8(2):161-169. PubMed ID: 30958310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of curcumin with manganese may compromise metal and neurotransmitter homeostasis in the hippocampus of young mice.
    Schmitz AE; de Oliveira PA; de Souza LF; da Silva DG; Danielski S; Santos DB; de Almeida EA; Prediger RD; Fisher A; Farina M; Dafre AL
    Biol Trace Elem Res; 2014 Jun; 158(3):399-409. PubMed ID: 24723215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
    Tang TS; Chen X; Liu J; Bezprozvanny I
    J Neurosci; 2007 Jul; 27(30):7899-910. PubMed ID: 17652581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity.
    O'Neal SL; Lee JW; Zheng W; Cannon JR
    Neurotoxicology; 2014 Sep; 44():303-13. PubMed ID: 25117542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal ER Ca
    Mackay JP; Smith-Dijak AI; Koch ET; Zhang P; Fung E; Nassrallah WB; Buren C; Schmidt M; Hayden MR; Raymond LA
    J Neurosci; 2023 May; 43(20):3743-3763. PubMed ID: 36944490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats.
    Tomás-Camardiel M; Herrera AJ; Venero JL; Cruz Sánchez-Hidalgo M; Cano J; Machado A
    Brain Res Mol Brain Res; 2002 Jun; 103(1-2):116-29. PubMed ID: 12106697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
    Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R
    Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Pearson J; Bailey CD; Rogers DA; Johnson GV; Hayden MR; Leavitt BR
    J Neurochem; 2005 Oct; 95(1):210-20. PubMed ID: 16181425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.
    Franciosi S; Ryu JK; Shim Y; Hill A; Connolly C; Hayden MR; McLarnon JG; Leavitt BR
    Neurobiol Dis; 2012 Jan; 45(1):438-49. PubMed ID: 21946335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbate deficiency decreases dopamine release in gulo
    Consoli DC; Brady LJ; Bowman AB; Calipari ES; Harrison FE
    J Neurochem; 2021 May; 157(3):656-665. PubMed ID: 32797675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Pearson J; Rogers DA; Bissada N; Vogl AW; Hayden MR; Leavitt BR
    Hum Mol Genet; 2005 May; 14(10):1379-92. PubMed ID: 15829505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.